You have 9 free searches left this month | to do more

Melphalan

Melphalan is a drug used to treat Lymphoma, Multiple Myeloma, Leukemia, and other conditions. Melphalan is being actively studied in 143 studies and prior, has been studied in 268.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterRoswell Park Cancer InstituteVaishali Sanchorawala
City of Hope Medical CenterFred Hutchinson Cancer Research CenterEdward Neuwelt
Fred Hutchinson Cancer Research CenterMemorial Sloan Kettering Cancer CenterJulie M Vose, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Completed
  • Multiple Myeloma
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
2021-07-29
Jul 29, 2021
S
Recruiting
  • Retinoblastoma
  • Chemotherapy Effect
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
2021-03-12
Mar 12, 2021
F
Active, not recruiting
  • Multiple Myeloma
  • Newly Diagnosed Patients
  • Melphalan
  • +2 more
  • Torino, Italy
    Division of Hematology, AOU Città della Salute e della Scienza d
2021-01-08
Jan 8, 2021
C
Completed
  • Hematopoietic Stem Cell Transplantation
  • Melphalan
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2021-08-24
Aug 24, 2021
S
Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Melphalan
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2021-06-23
Jun 23, 2021
U
Completed
  • Multiple Myeloma, Relapsed
  • Multiple Myeloma, Refractory to Standard Treatment
  • Total Marrow Irradiation
  • +3 more
  • Chicago, Illinois
    University of Illinois Cancer Center
2021-11-20
Nov 20, 2021
U
Completed
  • Hematologic Malignancies
  • +7 more
  • Melphalan
  • San Francisco, California
    University of California, San Francisco
2021-09-27
Sep 27, 2021
C
Recruiting
  • Leukemia
  • Melphalan
  • +3 more
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
2021-06-21
Jun 21, 2021
M
Active, not recruiting
  • Multiple Myeloma
  • Amyloidosis
  • Melphalan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-06-25
Jun 25, 2021
U
Recruiting
  • Cancer, Appendiceal
  • ColoRectal Cancer
  • Mitomycin c
  • Melphalan
  • Westwood, Kansas
    The University of Kansas Medical Center
2021-04-29
Apr 29, 2021
H
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-18
Nov 18, 2021
H
Active, not recruiting
  • Multiple Myeloma
  • Washington, District of Columbia
  • +1 more
2021-04-30
Apr 30, 2021
M
Completed
  • Myeloma
  • Trisenox (Arsenic Trioxide)
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
2020-09-01
Sep 1, 2020
C
Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • fludarabine phosphate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
2021-09-16
Sep 16, 2021
U
Terminated
  • Multiple Myeloma and Plasma Cell Neoplasm
  • melphalan
  • +2 more
  • Birmingham, England, United Kingdom
  • +2 more
2020-12-18
Dec 18, 2020
E
Recruiting
  • Multiple Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Atlanta, Georgia
  • +1 more
2021-06-02
Jun 2, 2021
C
Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Duarte, California
    City of Hope Medical Center
2021-02-15
Feb 15, 2021
U
Terminated
  • Advanced Intra-Ocular Retinoblastoma
  • Retinoblastoma
  • Melphalan
  • +3 more
  • San Francisco, California
    University of California, San Francisco
2020-04-14
Apr 14, 2020
C
Completed
  • Refractory Multiple Myeloma
  • +4 more
  • total marrow irradiation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
2021-02-25
Feb 25, 2021